FSC
TMO icon

Full Sail Capital’s Thermo Fisher Scientific TMO Stock Holding History

Full Sail Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$461K Sell
951
-1,186
-55% -$552K 0.03% 168
2025
Q2 		$866K Sell
2,137
-115
-5% -$48.1K 0.05% 100
2025
Q1 		$1.12M Buy
2,252
+83
+4% +$45K 0.07% 83
2024
Q4 		$1.13M Buy
2,169
+37
+2% +$20.3K 0.07% 81
2024
Q3 		$1.32M Sell
2,132
-580
-21% -$343K 0.08% 80
2024
Q2 		$1.5M Buy
2,712
+4
+0.1% +$2.29K 0.1% 78
2024
Q1 		$1.57M Sell
2,708
-546
-17% -$306K 0.11% 75
2023
Q4 		$1.73M Buy
3,254
+197
+6% +$95.4K 0.13% 72
2023
Q3 		$1.55M Buy
3,057
+210
+7% +$112K 0.13% 72
2023
Q2 		$1.49M Sell
2,847
-1,992
-41% -$1.07M 0.13% 74
2023
Q1 		$2.79M Buy
4,839
+315
+7% +$178K 0.25% 61
2022
Q4 		$2.49M Buy
4,524
+1
+0% +$530 0.24% 65
2022
Q3 		$2.29M Hold
4,523
– – 0.24% 64
2022
Q2 		$2.46M Sell
4,523
-401
-8% -$221K 0.24% 65
2022
Q1 		$2.91M Sell
4,924
-867
-15% -$498K 0.24% 63
2021
Q4 		$3.29M Sell
5,791
-99
-2% -$61.8K 0.29% 58
2021
Q3 		$3.37M Sell
5,890
-454
-7% -$249K 0.29% 57
2021
Q2 		$3.2M Hold
6,344
– – 0.29% 57
2021
Q1 		$2.97M Sell
6,344
-165
-3% -$78.8K 0.3% 58
2020
Q4 		$3.31M Sell
6,509
-163
-2% -$76.4K 0.36% 52
2020
Q3 		$3.43M Sell
6,672
-240
-3% -$99.2K 0.43% 47
2020
Q2 		$2.83M Sell
6,912
-628
-8% -$210K 0.4% 52
2020
Q1 		$2.51M Buy
7,540
+3,975
+112% +$1.25M 0.45% 47
2019
Q4 		$1.19M Hold
3,565
– – 0.25% 56
2019
Q3 		$1.07M Sell
3,565
-35
-1% -$10K 0.25% 61
2019
Q2 		$995K Buy
3,600
+1,395
+63% +$384K 0.28% 55
2019
Q1 		$604K Sell
2,205
-9
-0.4% -$2.24K 0.19% 68
2018
Q4 		$495K Buy
+2,214
New +$519K 0.24% 72

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Full Sail Capital's TMO Position: Q3 2025 in Review

Full Sail Capital reduced its Thermo Fisher Scientific (TMO) stake by 55% in Q3 2025, selling an estimated $552K and leaving 951 shares worth $461K. The position accounts for 0.03% of the portfolio, ranked #168.

Full Sail Capital first reported a position in TMO in Q4 2018 and has held it in 28 quarters since. The position peaked at $3.43M in Q3 2020. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Full Sail Capital held 951 shares of Thermo Fisher Scientific worth $461K as of Q3 2025.
  • Full Sail Capital sold 1,186 Thermo Fisher Scientific shares in Q3 2025, an estimated $552K.
  • Thermo Fisher Scientific made up 0.03% of Full Sail Capital's portfolio in Q3 2025, its #168 holding.
  • Full Sail Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 28 quarters since.
  • Full Sail Capital's Thermo Fisher Scientific position peaked at $3.43M in Q3 2020.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Full Sail Capital's 13F filing for Q3 2025, filed 14 Nov 2025.